MedTrace Logo

Evaluations of Alcohol Warning Labels

NCT06129487 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1053

Last updated 2025-11-14

Study results available
· View outcomes & findings →

Summary

The goal of this study is to determine the effectiveness of pictorial warning labels (PWLs) featuring narrative (vs. non-narrative) content in communicating the cancer risk of alcohol. Participants will be randomized to view either three narrative or non-narrative PWLs. Key outcome variables include visual attention, message reactance, risk perceptions, and intentions to reduce and stop drinking.

Conditions

  • Oral Cancer
  • Esophageal Cancer
  • Larynx Cancer
  • Alcohol Drinking

Interventions

BEHAVIORAL

Narrative pictorial warning labels for alcoholic beverages

Pictorial warning labels consisting of text and narrative imagery (e.g., photos of cancer patients) conveying the risk of alcohol for oral cancer, esophageal cancer, and larynx cancer.

BEHAVIORAL

Non-narrative pictorial warning labels for alcoholic beverages

Pictorial warning labels consisting of text and non-narrative imagery (e.g., images of diseased organs) conveying the risk of alcohol for oral cancer, esophageal cancer, and larynx cancer.

Sponsors & Collaborators

  • Oakland University

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Connecticut

    lead OTHER

Principal Investigators

  • Zexin Ma, Ph.D. · University of Connecticut

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-19
Primary Completion
2024-03-06
Completion
2024-03-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06129487 on ClinicalTrials.gov